Potentiation of etoposide-induced apoptosis in HeLa cells by co-treatment with KG-135, a quality-controlled standardized ginsenoside formulation

Cancer Letters

Volumn 294, Issue 1, 2010, Pages 74-81

  Lee, Won Hee ^a   Choi, Joon Seok ^a   Kim, Hyun Young ^a   Park, Jeong Hill ^a   Park, Byoung Duck ^a   Cho, Seung Ju ^a   Lee, Seung Ki ^a   Surh, Young Joon ^a  

^a Seoul National University   (South Korea)

Author keywords

Apoptosis; Etoposide; Ginseng; KG 135; P53

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1; ETOPOSIDE; GINSENG EXTRACT; KG 135; PROTEIN BAX; PROTEIN P53; SERINE; UNCLASSIFIED DRUG; WORTMANNIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG ISOLATION; DRUG POTENTIATION; GENE EXPRESSION; GENE LOCATION; GINSENG; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUALITY CONTROL; SIGNAL TRANSDUCTION;

ANDROSTADIENES; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUG SYNERGISM; ETOPOSIDE; FEMALE; GINSENOSIDES; HELA CELLS; HUMANS; KOREA; LIVER NEOPLASMS; MEDICINE, EAST ASIAN TRADITIONAL; MEMBRANE POTENTIALS; MITOCHONDRIA; MYCOTOXINS; PHOSPHOSERINE; STOMACH NEOPLASMS;

PANAX GINSENG;

EID: 77953027035     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.01.024     Document Type: Article

References (30)

1. American Society of Health-System Pharmacists, AHFS Drug Information, 2007, 1034p.
2. Bristol-Myers Squibb, Etopophos Product Information, 2005, 12p.
3. Hisashi M., Mitsuo K., Tetsuya S., Hiroshi Y., Masato M. Potentiation of cytotoxicity of mitomycin C by a polyacetylenic alcohol, panaxytriol. Cancer Chemother. Pharmacol. 1994, 33:291-297.
4. Waf1 leading to induction of apoptosis in SK-HEP-1 cells. Anticancer Res. 1999, 19:487-491.
5. Oh M., Choi Y.H., Choi S., Chung H., Kim K., Kim S.I., Kim D.K., Kim N.D. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int. J. Oncol. 1999, 14:869-875.
6. Cheng C.C., Yang S.M., Huang C.Y., Chen J.C., Chang W.M., Hsu S.L. Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother. Pharmacol. 2005, 55:531-540.
7. Waf1/Cip1 protein levels in mammalian cells. Carcinogenesis 2003, 24:1767-1772.
8. Yun T.K. Experimental and epidemiological evidence of the cancer preventive effects of Panax ginseng C.A. Meyer. Nutr. Rev. 1996, 54:S71-S81. (Review).
9. Yun T.K., Choi S.Y. Preventive effect of ginseng intake against various human cancers: a case control study on pairs. Cancer Epidemiol. Biomarkers Prev. 1995, 4:401-408.
10. Wang C.Z., Aung H.H., Ni M., Wu J.A., Tong R., Wicks S., He T.C., Yuan C.S. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius Roots. Planta Med. 2007, 73:669-674.
11. Yun T.K., Lee Y.S., Lee Y.H., Kim S.I., Yun H.Y. Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J. Korean Med. Sci. 2001, 16:S6-S18.
12. Waf1 in human hepatoma SK-HEP-1 cells. Eur. J. Cancer 1999, 35:507-511.
13. Waf1/Cip1 and down-regulating cyclin E in SK-HEP-1 cells. Anticancer Res. 1997, 17:1067-1072.
14. Kip1. Cancer Lett. 1996, 110:193-200.
15. Kwon S.W., Han S.B., Park I.H., Kim J.M., Park M.K., Park J.H. Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J. Chromatogr. A 2001, 921:335-339.
16. Ashcroft M., Vousden K.H. Regulation of p53 stability. Oncogene 1999, 18:7637-7643.
17. Appella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 2001, 268:2764-2772.
18. Lavin M.F., Gueven N. The complexity of p53 stabilization and activation. Cell Death Differ. 2006, 13:941-950.
19. Pu Y.S., Hsieh M.W., Wang C.W., Liu G.Y., Huang C.Y., Lin C.C., Guan J.Y., Line S.R., Hour T.C. Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells. Biochem. Pharmacol. 2006, 71:751-760.
20. Zhang X., Yashiro M., Ren J., Hirakawa K. Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. Oncol. Rep. 2006, 16:563-568.
21. Awara W.M., El-Sisi A.E., El-Sayad M.E., Goda A.E. The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?. Pharmacol.. Res. 2004, 50:487-498.
22. Steele R.J., Thompson A.M., Hall P.A., Lane D.P. The p53 tumour suppressor gene. Brit. J. Surg. 1998, 11:1460-1467.
23. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998, 281:1677-1679.
24. Banin S., Moyal L., Shieh S.Y., Taya Y., Anderson C.W., Chessa L., Smorodinsky N.I., Prives C., Reiss Y., Shiloh Y., Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998, 281:1674-1677.
25. Nakagawa K., Taya Y., Tamai K., Yamaizumi M. Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks. Mol. Cell. Biol. 1999, 19:2828-2834.
26. Shieh S.Y., Ikeda M., Taya Y., Prives C. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997, 91:325-334.
27. Zhang Y., Xiong Y. A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 2001, 292:1910-1915.
28. Khanna K.K., Keating K.E., Kozlov S., Scott S., Gatei M., Hobson K., Taya Y., Gabrielli B., Chan D., Lees-Miller S.P., Lavin M.F. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet. 1998, 20:398-400.
29. Apella E., Anderson C.W. Post-translational modifications and activation of p53 by genotoxic stresses. Eur. J. Biochem. 2001, 268:2764-2772.
30. Saito S., Yamaguchi H., Higashimoto Y., Chao C., Xu Y., Fornace A.J., Appella E., Anderson C.W. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J. Biol. Chem. 2003, 278:37536-37544.